X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1124) 1124
Publication (168) 168
Newsletter (18) 18
Book Review (8) 8
Book Chapter (6) 6
Dissertation (4) 4
Web Resource (2) 2
Book / eBook (1) 1
Conference Proceeding (1) 1
Data Set (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (697) 697
isoniazid (494) 494
male (489) 489
tuberculosis (463) 463
index medicus (440) 440
female (399) 399
isoniazid - pharmacokinetics (391) 391
pharmacology & pharmacy (364) 364
adult (322) 322
antitubercular agents - pharmacokinetics (311) 311
pharmacokinetics (285) 285
animals (271) 271
isoniazid - administration & dosage (258) 258
isoniazid - therapeutic use (231) 231
antitubercular agents - therapeutic use (224) 224
antitubercular agents - administration & dosage (221) 221
middle aged (214) 214
rifampin (214) 214
tuberculosis - drug therapy (208) 208
tuberculosis, pulmonary - drug therapy (190) 190
microbiology (189) 189
rifampin - pharmacokinetics (189) 189
infectious diseases (186) 186
pyrazinamide (186) 186
rifampicin (178) 178
isoniazid - blood (164) 164
isoniazid - pharmacology (163) 163
rifampin - administration & dosage (163) 163
mycobacterium tuberculosis - drug effects (158) 158
pulmonary tuberculosis (154) 154
rifampin - therapeutic use (143) 143
mycobacterium-tuberculosis (136) 136
mice (124) 124
drug therapy, combination (122) 122
drugs (122) 122
antitubercular agents - pharmacology (117) 117
adolescent (114) 114
drug therapy (113) 113
pyrazinamide - pharmacokinetics (112) 112
respiratory system (112) 112
acetylation (109) 109
antitubercular agents - blood (105) 105
aged (102) 102
drug interactions (102) 102
research (95) 95
antituberculosis drugs (94) 94
antitubercular agents (92) 92
rifampin - blood (91) 91
drug resistance (90) 90
ethambutol (90) 90
rats (89) 89
treatment outcome (89) 89
time factors (88) 88
area under curve (87) 87
mycobacterium tuberculosis (86) 86
biological availability (85) 85
phenotype (85) 85
pharmacology (84) 84
kinetics (82) 82
child (80) 80
research article (80) 80
dose-response relationship, drug (78) 78
pyrazinamide - administration & dosage (78) 78
isoniazid - metabolism (76) 76
pyrazinamide - therapeutic use (76) 76
analysis (75) 75
metabolism (75) 75
half-life (74) 74
medicine (74) 74
drug administration schedule (71) 71
genotype (71) 71
hiv (71) 71
hepatotoxicity (69) 69
drug combinations (68) 68
immunology (68) 68
isoniazid - adverse effects (68) 68
antitubercular agents - adverse effects (67) 67
chemotherapy (67) 67
bacterial infections and mycoses (66) 66
health aspects (66) 66
dosage and administration (65) 65
young adult (65) 65
administration, oral (64) 64
bioavailability (63) 63
rifampin - pharmacology (63) 63
child, preschool (61) 61
microbial sensitivity tests (61) 61
therapy (61) 61
arylamine n-acetyltransferase - genetics (59) 59
infant (57) 57
isoniazid - analogs & derivatives (56) 56
medicine, general & internal (56) 56
pyrazinamide - blood (56) 56
children (55) 55
article (53) 53
isoniazid - chemistry (53) 53
risk factors (52) 52
tuberculosis, pulmonary - microbiology (52) 52
chromatography, high pressure liquid (51) 51
in-vitro (51) 51
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1064) 1064
Russian (35) 35
German (12) 12
French (11) 11
Chinese (7) 7
Polish (5) 5
Japanese (4) 4
Portuguese (4) 4
Italian (3) 3
Korean (3) 3
Spanish (3) 3
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Infectious Diseases, ISSN 1058-4838, 6/2009, Volume 48, Issue 12, pp. 1685 - 1694
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 07/2011, Volume 55, Issue 7, pp. 3244 - 3253
Journal Article
The Journal of Infectious Diseases, ISSN 0022-1899, 11/2013, Volume 208, Issue 9, pp. 1464 - 1473
Journal Article
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 01/2012, Volume 56, Issue 1, pp. 446 - 457
Journal Article
Expert Opinion on Drug Metabolism & Toxicology, ISSN 1742-5255, 06/2014, Volume 10, Issue 6, pp. 813 - 823
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2017, Volume 61, Issue 2, p. AAC.01701-16
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 01/2019, Volume 68, Issue 3, pp. 446 - 452
Abstract Background The World Health Organization recommends efavirenz 400 mg (EFV400) as first-line antiretroviral therapy, with a disclaimer that no data... 
INFECTIOUS DISEASES | EFFICACY | tuberculosis | isoniazid/rifampicin | MICROBIOLOGY | IMMUNOLOGY | low-dose efavirenz | IMPACT | CYP2B6 | POLYMORPHISMS | HIV | PLASMA-CONCENTRATIONS | pharmacokinetics | DOUBLE-BLIND | WEIGHT | TUBERCULOSIS TREATMENT | EXPOSURE
Journal Article
INDIAN JOURNAL OF PEDIATRICS, ISSN 0019-5456, 05/2019, Volume 86, Issue 5, pp. 468 - 478
Determining the optimal dosages of isoniazid, rifampicin, pyrazinamide and ethambutol in children is necessary to obtain therapeutic serum concentrations of... 
ANTITUBERCULOSIS DRUGS | Pyrazinamide | CEREBROSPINAL-FLUID | ISONIAZID PHARMACOKINETICS | Anti tuberculosis drugs | Rifampicin | PLASMA-CONCENTRATIONS | NUTRITIONAL-STATUS | SERUM-LEVELS | Ethambutol | PEDIATRICS | TB DRUGS | Isoniazid | SOUTH-AFRICAN CHILDREN
Journal Article